World won't finish with Covid-19 by end-2021: World Health Organisation

The World Health Organization (WHO) said that it is "unrealistic" to expect the Covid-19 pandemic to be over by the end of 2021

WHO
The United States played a pivotal role in helping to create the WHO in 1948. Just over 70 years later, President Trump is withdrawing the country from the agency amid the COVID-19 pandemic. Martial Trezzini/EPA
IANS Geneva
2 min read Last Updated : Mar 02 2021 | 7:42 AM IST

The World Health Organization (WHO) said that it is "unrealistic" to expect the Covid-19 pandemic to be over by the end of 2021.

"I think it will be very premature, and I think unrealistic, to think that we're going to finish with this virus by the end of the year," Dr. Michael Ryan, executive director of the WHO's Health Emergencies Program, said at a press conference here on Monday, Xinhua news agency reported.

"But I think what we can, if we're smart, finish with the hospitalizations, the deaths and the tragedy associated with this pandemic," he said.

Dr. Soumya Swaminathan, chief scientist of the WHO, added that "the goal of COVAX is to bring an end to the acute phase of the pandemic by the end of 2021."

COVAX is a program led by the WHO, Gavi (the Vaccine Alliance) and the Coalition for Epidemic Preparedness Innovations (CEPI) aiming at distributing Covid-19 vaccines around the world.

"We still face a huge challenge in rolling out vaccines equitably and fairly to those who most need them around the world," Ryan said.

"We're in a much better position than we were. But nothing is guaranteed," he added.

As the world is struggling to contain the pandemic, vaccination is underway in some countries with the already-authorized coronavirus vaccines.

Meanwhile, 256 candidate vaccines are still being developed worldwide -- 74 of them in clinical trials -- in countries including Germany, China, Russia, Britain and the United States, according to information released by the WHO on February 26.

--IANS

int/

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusWorld Health OrganisationWHO

First Published: Mar 02 2021 | 7:38 AM IST

Next Story